Drug Profile
C 8585
Alternative Names: c-8585Latest Information Update: 18 Feb 2008
Price :
$50
*
At a glance
- Originator Merck & Co
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Feb 2005 Phase-I clinical trials in Cancer in USA (unspecified route)